Trial of Variable Dialysate Bicarbonate

NARecruitingINTERVENTIONAL
Enrollment

141

Participants

Timeline

Start Date

August 24, 2023

Primary Completion Date

September 1, 2026

Study Completion Date

October 1, 2026

Conditions
Peri-dialytic Cardiac RhythmsIntradialytic HypotensionElectrolyte ChangespH ChangesAdverse Symptoms
Interventions
DRUG

Dialysate bicarbonate concentration

"Assess how a lower dialysate bicarbonate affects:~* QTc duration during and between hemodialysis sessions~* PVC burden during and between hemodialysis sessions~* Clinically significant arrhythmia during and between hemodialysis sessions~* Intradialytic hypotension~* Adverse symptoms during hemodialysis sessions"

DEVICE

Dialysate bicarbonate concentration - telemetry monitoring

Patients will be monitored with telemetry on both arms of the trial.

Trial Locations (1)

02115

RECRUITING

Brigham and Women's Hospital, Boston

All Listed Sponsors
lead

Brigham and Women's Hospital

OTHER